|
OMIM |
Link |
Information gain |
01 |
|
small cell cancer of the lung
|
[NCBI]
|
0.0138028
|
|
|
PWS
|
[NCBI]
|
0.00933182
|
|
|
chromosome 10q deletion syndrome
|
[NCBI]
|
0.0070948
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
0.00692917
|
|
|
DGS
|
[NCBI]
|
0.0067697
|
|
|
WHS
|
[NCBI]
|
0.00615729
|
|
|
SHFM1
|
[NCBI]
|
0.00573208
|
|
|
AS
|
[NCBI]
|
0.00543752
|
|
|
MCOPS6
|
[NCBI]
|
0.00420304
|
|
|
SLE
|
[NCBI]
|
0.00416969
|
|
|
SMS
|
[NCBI]
|
0.00409499
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
0.00372472
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
0.00364369
|
|
|
melanoma, uveal, susceptibility to, 2
|
[NCBI]
|
0.00283062
|
|
|
TRPS2
|
[NCBI]
|
0.00275177
|
|
|
WT1
|
[NCBI]
|
0.00261554
|
|
|
BRCD1
|
[NCBI]
|
0.00260744
|
|
|
GCY
|
[NCBI]
|
0.0024332
|
|
|
DWS
|
[NCBI]
|
0.002293153
|
|
|
DIH2
|
[NCBI]
|
0.00217112
|
|
|
RB1
|
[NCBI]
|
0.002028901
|
|
|
AMMECR1
|
[NCBI]
|
0.001876355
|
|
|
brachydactyly-mental retardation syndrome
|
[NCBI]
|
0.001876355
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
0.001876355
|
|
|
SHFM5
|
[NCBI]
|
0.001675906
|
|
|
holoprosencephaly
|
[NCBI]
|
0.001670184
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
0.00164407
|
|
|
JBS
|
[NCBI]
|
0.001509733
|
|
|
DMD
|
[NCBI]
|
0.001480981
|
|
|
WBS
|
[NCBI]
|
0.001455147
|
|
|
AIC
|
[NCBI]
|
0.001433917
|
|
|
melanoma, uveal, susceptibility to, 1
|
[NCBI]
|
0.001414101
|
|
|
HPE8
|
[NCBI]
|
0.001414101
|
|
|
larsen-like syndrome
|
[NCBI]
|
0.001414101
|
|
|
3q29 microdeletion syndrome
|
[NCBI]
|
0.001414101
|
|
|
holoprosencephaly 6
|
[NCBI]
|
0.001414101
|
|
|
MTACR1
|
[NCBI]
|
0.001298947
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
0.001270489
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
0.001261747
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
0.001261747
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.001226987
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.001211355
|
|
|
multiple mitochondrial dysfunctions syndrome
|
[NCBI]
|
0.001152521
|
|
|
CHR
|
[NCBI]
|
0.001152521
|
|
|
PCA
|
[NCBI]
|
0.00113492
|
|
|
MDLS
|
[NCBI]
|
0.000970456
|
|
|
persistent hyperplastic primary vitreous, autosomal dominant
|
[NCBI]
|
0.000937014
|
|
|
hypercalciuria, absorptive, 1
|
[NCBI]
|
0.000937014
|
|
|
aural atresia, congenital
|
[NCBI]
|
0.000937014
|
|
|
hydrocephalus, autosomal dominant
|
[NCBI]
|
0.000937014
|
|
|
tumor suppressor gene on chromosome 11
|
[NCBI]
|
0.000937014
|
|
|
CORD1
|
[NCBI]
|
0.000937014
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
0.000932388
|
|
|
CBBM
|
[NCBI]
|
0.00092913
|
|
|
KSS
|
[NCBI]
|
0.000927371
|
|
|
GCPS
|
[NCBI]
|
0.00092102
|
|
|
hyperglycerolemia
|
[NCBI]
|
0.000875503
|
|
|
RCC1
|
[NCBI]
|
0.000861437
|
|
|
nablus mask-like facial syndrome
|
[NCBI]
|
0.000857199
|
|
|
ST8
|
[NCBI]
|
0.000854402
|
|
|
VEGF
|
[NCBI]
|
0.000811634
|
|
|
TRPS1
|
[NCBI]
|
0.000810387
|
|
|
TNF
|
[NCBI]
|
0.000781178
|
|
|
axenfeld-rieger anomaly with cardiac defects and sensorineural hearing loss
|
[NCBI]
|
0.000760733
|
|
|
MRX2
|
[NCBI]
|
0.000760733
|
|
|
b-cell malignancy, low-grade
|
[NCBI]
|
0.000760733
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000709761
|
|
|
cri-du-chat syndrome
|
[NCBI]
|
0.000705801
|
|
|
ND
|
[NCBI]
|
0.000686356
|
|
|
CTHM
|
[NCBI]
|
0.000670869
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
0.000661363
|
|
|
BPES
|
[NCBI]
|
0.000659078
|
|
|
monosomy 7 of bone marrow
|
[NCBI]
|
0.000651267
|
|
|
RIEG2
|
[NCBI]
|
0.000648392
|
|
|
horner syndrome, congenital
|
[NCBI]
|
0.000648392
|
|
|
BRCA3
|
[NCBI]
|
0.000648392
|
|
|
HBB
|
[NCBI]
|
0.000648303
|
|
|
carnosinemia
|
[NCBI]
|
0.000611119
|
|
|
wagr syndrome
|
[NCBI]
|
0.000609364
|
|
|
neuroblastoma
|
[NCBI]
|
0.000608775
|
|
|
POF1
|
[NCBI]
|
0.000600841
|
|
|
CDPX1
|
[NCBI]
|
0.000579159
|
|
|
ALGS1
|
[NCBI]
|
0.000572639
|
|
|
monosomy 1p36 syndrome
|
[NCBI]
|
0.000571572
|
|
|
WT3
|
[NCBI]
|
0.000566418
|
|
|
CTAA1
|
[NCBI]
|
0.000566418
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
0.000540747
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
0.000540747
|
|
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
0.000537958
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.000531536
|
|
|
CNC2
|
[NCBI]
|
0.000531536
|
|
|
HEMB
|
[NCBI]
|
0.000524784
|
|
|
CF
|
[NCBI]
|
0.000520207
|
|
|
HBFQTL1
|
[NCBI]
|
0.000514123
|
|
|
AN2
|
[NCBI]
|
0.000507048
|
|
|
pituitary dwarfism i
|
[NCBI]
|
0.00050613
|
|
|
subglottic bar
|
[NCBI]
|
0.000505
|
|
|
hemophilia a
|
[NCBI]
|
0.000502292
|
|
|
meningioma, familial
|
[NCBI]
|
0.000493924
|
|
|
DAZ
|
[NCBI]
|
0.000492506
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000478635
|
|
|
CMM
|
[NCBI]
|
0.000475686
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.000473937
|
|
|
AUTS4
|
[NCBI]
|
0.000473937
|
|
|
apc gene
|
[NCBI]
|
0.000472146
|
|
|
FRNS
|
[NCBI]
|
0.000470131
|
|
|
MDD
|
[NCBI]
|
0.0004618384
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
0.000461764
|
|
|
DMD
|
[NCBI]
|
0.000460323
|
|
|
MCOPS7
|
[NCBI]
|
0.000453323
|
|
|
SHFM2
|
[NCBI]
|
0.000450064
|
|
|
LDLR
|
[NCBI]
|
0.000449691
|
|
|
ISS
|
[NCBI]
|
0.000433955
|
|
|
HSCR2
|
[NCBI]
|
0.00041864
|
|
|
CRS1
|
[NCBI]
|
0.000417795
|
|
|
RIEG1
|
[NCBI]
|
0.000415981
|
|
|
esophageal cancer
|
[NCBI]
|
0.000403909
|
|
|
CRC
|
[NCBI]
|
0.000403225
|
|
|
KLK3
|
[NCBI]
|
0.0003954811
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.000373895
|
|
|
BMD
|
[NCBI]
|
0.000367575
|
|
|
HBA1
|
[NCBI]
|
0.000366107
|
|
|
TBX1
|
[NCBI]
|
0.000356128
|
|
|
monosomy 9p syndrome
|
[NCBI]
|
0.000343361
|
|
|
PBT
|
[NCBI]
|
0.000334519
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
0.000334473
|
|
|
KAL1
|
[NCBI]
|
0.000327893
|
|
|
HNPP
|
[NCBI]
|
0.000326032
|
|
|
MRX21
|
[NCBI]
|
0.000325514
|
|
|
TCPT
|
[NCBI]
|
0.000325514
|
|
|
CHM
|
[NCBI]
|
0.000315202
|
|
|
SHOX
|
[NCBI]
|
0.000310861
|
|
|
PRL
|
[NCBI]
|
0.000308425
|
|
|
BWS
|
[NCBI]
|
0.000300597
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000299892
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.00029918
|
|
|
ESD
|
[NCBI]
|
0.000298688
|
|
|
chromosome 9q subtelomeric deletion syndrome
|
[NCBI]
|
0.000297485
|
|
|
mental and growth retardation with amblyopia
|
[NCBI]
|
0.000297485
|
|
|
CTS1
|
[NCBI]
|
0.0002974407
|
|
|
chromosome 18p deletion syndrome
|
[NCBI]
|
0.000297347
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
0.00029037
|
|
|
CDH13
|
[NCBI]
|
0.000284129
|
|
|
oca2 gene
|
[NCBI]
|
0.000281664
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000281452
|
|
|
WT5
|
[NCBI]
|
0.000275428
|
|
|
AHO
|
[NCBI]
|
0.000275007
|
|
|
HBA2
|
[NCBI]
|
0.000270259
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
0.000269907
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
0.000267369
|
|
|
keratosis pilaris
|
[NCBI]
|
0.00026677
|
|
|
WM1
|
[NCBI]
|
0.0002662427
|
|
|
RSTS
|
[NCBI]
|
0.000257456
|
|
|
NF1
|
[NCBI]
|
0.000247399
|
|
|
AIED
|
[NCBI]
|
0.000246258
|
|
|
CHM
|
[NCBI]
|
0.00024528
|
|
|
PTHS
|
[NCBI]
|
0.0002436546
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
0.000243103
|
|
|
mesothelioma, malignant
|
[NCBI]
|
0.000240038
|
|
|
glioma of brain, familial
|
[NCBI]
|
0.000239656
|
|
|
HBG1
|
[NCBI]
|
0.0002355191
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
0.0002318201
|
|
|
MTAP
|
[NCBI]
|
0.0002303595
|
|
|
GUD
|
[NCBI]
|
0.00022888
|
|
|
hypotonia-cystinuria syndrome
|
[NCBI]
|
0.00022888
|
|
|
PCNA
|
[NCBI]
|
0.0002252803
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
0.00022388
|
|
|
NGFB
|
[NCBI]
|
0.000223824
|
|
|
SHANK3
|
[NCBI]
|
0.0002219265
|
|
|
APRT
|
[NCBI]
|
0.0002211523
|
|
|
IGHG1
|
[NCBI]
|
0.000217934
|
|
|
PTH
|
[NCBI]
|
0.0002157773
|
|
|
CMM2
|
[NCBI]
|
0.000215253
|
|
|
GLDC
|
[NCBI]
|
0.00021406
|
|
|
DURS1
|
[NCBI]
|
0.000210885
|
|
|
FMF
|
[NCBI]
|
0.000205686
|
|
|
GLA
|
[NCBI]
|
0.0002013139
|
|
|
anal atresia, hypospadias, and penoscrotal inversion
|
[NCBI]
|
0.0001982053
|
|
|
ST3
|
[NCBI]
|
0.0001981553
|
|
|
SMMCI
|
[NCBI]
|
0.0001959425
|
|
|
MRX1
|
[NCBI]
|
0.0001943894
|
|
|
MPO
|
[NCBI]
|
0.0001915504
|
|
|
pheochromocytoma
|
[NCBI]
|
0.0001888673
|
|
|
SVAS
|
[NCBI]
|
0.0001875653
|
|
|
PFM2
|
[NCBI]
|
0.0001867018
|
|
|
SIX6
|
[NCBI]
|
0.0001848278
|
|
|
DCC
|
[NCBI]
|
0.0001835309
|
|
|
ACHE
|
[NCBI]
|
0.0001821014
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
0.0001814821
|
|
|
HPE3
|
[NCBI]
|
0.0001814821
|
|
|
FSHMD1A
|
[NCBI]
|
0.0001800462
|
|
|
TH
|
[NCBI]
|
0.0001789962
|
|
|
USP9Y
|
[NCBI]
|
0.0001781503
|
|
|
CFTD
|
[NCBI]
|
0.0001752183
|
|
|
GFAP
|
[NCBI]
|
0.0001741286
|
|
|
SHFM3
|
[NCBI]
|
0.0001716575
|
|
|
OTC
|
[NCBI]
|
0.0001716047
|
|
|
TS
|
[NCBI]
|
0.0001711828
|
|
|
gastric cancer
|
[NCBI]
|
0.0001695685
|
|
|
MN
|
[NCBI]
|
0.0001657204
|
|
|
IGAD1
|
[NCBI]
|
0.0001650501
|
|
|
WT1
|
[NCBI]
|
0.0001648365
|
|
|
HGF
|
[NCBI]
|
0.000163967
|
|
|
NSD1
|
[NCBI]
|
0.0001617626
|
|
|
CFTR
|
[NCBI]
|
0.000161662
|
|
|
OCA4
|
[NCBI]
|
0.0001614871
|
|
|
HS
|
[NCBI]
|
0.0001603849
|
|
|
DHFR
|
[NCBI]
|
0.0001600144
|
|
|
NDP
|
[NCBI]
|
0.0001580578
|
|
|
SNRPN
|
[NCBI]
|
0.0001564264
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
0.0001562846
|
|
|
breast cancer-related regulator of tp53
|
[NCBI]
|
0.0001544797
|
|
|
GNB1L
|
[NCBI]
|
0.0001544797
|
|
|
leucyl-trna synthetase, mitochondrial
|
[NCBI]
|
0.0001544797
|
|
|
ALX4
|
[NCBI]
|
0.000153271
|
|
|
PAX6
|
[NCBI]
|
0.0001526956
|
|
|
MTCO2
|
[NCBI]
|
0.0001523806
|
|
|
homozygous 11p15-p14 deletion syndrome
|
[NCBI]
|
0.000148729
|
|
|
anal canal carcinoma
|
[NCBI]
|
0.000148729
|
|
|
albright hereditary osteodystrophy 2
|
[NCBI]
|
0.000148729
|
|
|
XRS
|
[NCBI]
|
0.000148729
|
|
|
renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial dna
|
[NCBI]
|
0.000148729
|
|
|
FRA11B
|
[NCBI]
|
0.000148729
|
|
|
incisors, lower central, absence of
|
[NCBI]
|
0.000148729
|
|
|
BDNF
|
[NCBI]
|
0.0001472613
|
|
|
GH1
|
[NCBI]
|
0.0001458183
|
|
|
ARSE
|
[NCBI]
|
0.0001457123
|
|
|
XK
|
[NCBI]
|
0.0001455401
|
|
|
pancreatic carcinoma
|
[NCBI]
|
0.0001445489
|
|
|
AN1
|
[NCBI]
|
0.0001439277
|
|
|
EHMT1
|
[NCBI]
|
0.0001431525
|
|
|
PPM1B
|
[NCBI]
|
0.0001431525
|
|
|
locus control region, alpha
|
[NCBI]
|
0.0001431525
|
|
|
SKI
|
[NCBI]
|
0.0001416824
|
|
|
HLA-A
|
[NCBI]
|
0.0001416052
|
|
|
factor x deficiency
|
[NCBI]
|
0.0001404737
|
|
|
ODG2
|
[NCBI]
|
0.0001380678
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
0.0001380514
|
|
|
POU6F2
|
[NCBI]
|
0.0001380514
|
|
|
EGF
|
[NCBI]
|
0.0001378105
|
|
|
RPE
|
[NCBI]
|
0.00013456
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
0.0001339521
|
|
|
mitochondrial myopathy
|
[NCBI]
|
0.0001330517
|
|
|
CSHL1
|
[NCBI]
|
0.0001318923
|
|
|
xx male syndrome
|
[NCBI]
|
0.000128936
|
|
|
VIP
|
[NCBI]
|
0.0001283806
|
|
|
SRA2
|
[NCBI]
|
0.0001255043
|
|
|
LPL
|
[NCBI]
|
0.0001254153
|
|
|
LIMD1
|
[NCBI]
|
0.0001242639
|
|
|
ALPI
|
[NCBI]
|
0.0001237517
|
|
|
MEN2A
|
[NCBI]
|
0.0001232443
|
|
|
AL-A1
|
[NCBI]
|
0.0001226477
|
|
|
RAI1
|
[NCBI]
|
0.0001225904
|
|
|
CSF1R
|
[NCBI]
|
0.0001219392
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
0.0001217179
|
|
|
glutaryl-coa oxidase deficiency
|
[NCBI]
|
0.0001213221
|
|
|
ETF1
|
[NCBI]
|
0.0001198723
|
|
|
XIST
|
[NCBI]
|
0.0001196242
|
|
|
CSF2
|
[NCBI]
|
0.000119231
|
|
|
PRY
|
[NCBI]
|
0.0001191628
|
|
|
IGHG3
|
[NCBI]
|
0.0001191628
|
|
|
IGHA1
|
[NCBI]
|
0.0001191628
|
|
|
PREPL
|
[NCBI]
|
0.0001191628
|
|
|
APOA1
|
[NCBI]
|
0.0001186353
|
|
|
ELN
|
[NCBI]
|
0.0001166082
|
|
|
AHC
|
[NCBI]
|
0.000116102
|
|
|
RASA1
|
[NCBI]
|
0.0001156881
|
|
|
PRDM2
|
[NCBI]
|
0.0001156714
|
|
|
REEP5
|
[NCBI]
|
0.0001156714
|
|
|
TRIM13
|
[NCBI]
|
0.0001156714
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
0.0001153437
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.0001152403
|
|
|
JBTS1
|
[NCBI]
|
0.000115114
|
|
|
HBZ
|
[NCBI]
|
0.0001140948
|
|
|
IRID1
|
[NCBI]
|
0.0001139045
|
|
|
CNTN4
|
[NCBI]
|
0.0001130037
|
|
|
GTS
|
[NCBI]
|
0.0001124504
|
|
|
ZEB2
|
[NCBI]
|
0.000111582
|
|
|
FA
|
[NCBI]
|
0.0001113416
|
|
|
MBS
|
[NCBI]
|
0.0001111988
|
|
|
WS3
|
[NCBI]
|
0.0001110447
|
|
|
CTRB1
|
[NCBI]
|
0.000110843
|
|
|
SRP19
|
[NCBI]
|
0.000110843
|
|
|
GSR
|
[NCBI]
|
0.0001094393
|
|
|
MCC
|
[NCBI]
|
0.0001071858
|
|
|
VCX3A
|
[NCBI]
|
0.0001071858
|
|
|
HEXB
|
[NCBI]
|
0.0001061405
|
|
|
PDGFRA
|
[NCBI]
|
0.0001059291
|
|
|
F12
|
[NCBI]
|
0.0001059291
|
|
|
ATD1
|
[NCBI]
|
0.0001047003
|
|
|
CDY1
|
[NCBI]
|
0.0001045181
|
|
|
EGFR
|
[NCBI]
|
0.0001033471
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.0001028485
|
|
|
HPE2
|
[NCBI]
|
0.0001026314
|
|
|
medulloblastoma
|
[NCBI]
|
0.0001026314
|
|
|
APC
|
[NCBI]
|
0.0001022989
|
|
|
FDH
|
[NCBI]
|
0.0001019405
|
|
|
neuroblastoma stage 4s gene
|
[NCBI]
|
0.0001013899
|
|
|
DMRT1
|
[NCBI]
|
0.0001005419
|
|
|
MYB
|
[NCBI]
|
0.0001002051
|
|
|
MCOPS3
|
[NCBI]
|
0.0001000715
|
|
|
CDKN2A
|
[NCBI]
|
9.99361e-05
|
|
|
TSC1
|
[NCBI]
|
9.94478e-05
|
|
|
chromosome 18 pericentric inversion
|
[NCBI]
|
9.90893e-05
|
|
|
williams-beuren region duplication syndrome
|
[NCBI]
|
9.90893e-05
|
|
|
dk phocomelia syndrome
|
[NCBI]
|
9.90893e-05
|
|
|
laryngeal web, familial
|
[NCBI]
|
9.90893e-05
|
|
|
bor-duane hydrocephalus contiguous gene syndrome
|
[NCBI]
|
9.90893e-05
|
|
|
USH1C
|
[NCBI]
|
9.90164e-05
|
|
|
HBQ1
|
[NCBI]
|
9.89769e-05
|
|
|
PI
|
[NCBI]
|
9.88598e-05
|
|
|
RPS14
|
[NCBI]
|
9.87707e-05
|
|
|
RBBP9
|
[NCBI]
|
9.87222e-05
|
|
|
HBE1
|
[NCBI]
|
9.76024e-05
|
|
|
F3
|
[NCBI]
|
9.72304e-05
|
|
|
MIRN15A
|
[NCBI]
|
9.65615e-05
|
|
|
SIL
|
[NCBI]
|
9.65615e-05
|
|
|
IGHM
|
[NCBI]
|
9.63775e-05
|
|
|
COL1A2
|
[NCBI]
|
9.49777e-05
|
|
|
FMO2
|
[NCBI]
|
9.34152e-05
|
|
|
CLL
|
[NCBI]
|
9.33982e-05
|
|
|
HRPT2
|
[NCBI]
|
9.32639e-05
|
|
|
HBFQTL2
|
[NCBI]
|
9.30924e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
9.24873e-05
|
|
|
DGCR14
|
[NCBI]
|
9.21418e-05
|
|
|
BCR
|
[NCBI]
|
9.16942e-05
|
|
|
CSH1
|
[NCBI]
|
9.02851e-05
|
|
|
HRAS
|
[NCBI]
|
8.95975e-05
|
|
|
PFM
|
[NCBI]
|
8.94777e-05
|
|
|
EPO
|
[NCBI]
|
8.93791e-05
|
|
|
autism, x-linked, susceptibility to, 2
|
[NCBI]
|
8.89732e-05
|
|
|
MIRN16-1
|
[NCBI]
|
8.87613e-05
|
|
|
C4B
|
[NCBI]
|
8.82755e-05
|
|
|
ORM1
|
[NCBI]
|
8.79023e-05
|
|
|
AK1
|
[NCBI]
|
8.76018e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
8.7477e-05
|
|
|
pitt syndrome
|
[NCBI]
|
8.7477e-05
|
|
|
Ss
|
[NCBI]
|
8.73868e-05
|
|
|
BIRC1
|
[NCBI]
|
8.67131e-05
|
|
|
THRB
|
[NCBI]
|
8.57239e-05
|
|
|
pachygyria with mental retardation and seizures
|
[NCBI]
|
8.55785e-05
|
|
|
TFAP2C
|
[NCBI]
|
8.51888e-05
|
|
|
SEMA3F
|
[NCBI]
|
8.40534e-05
|
|
|
NF2
|
[NCBI]
|
8.36132e-05
|
|
|
TCF4
|
[NCBI]
|
8.31324e-05
|
|
|
C1NH
|
[NCBI]
|
8.21842e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
8.17401e-05
|
|
|
TFAP2A
|
[NCBI]
|
8.14854e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
8.13261e-05
|
|
|
RDT
|
[NCBI]
|
8.12152e-05
|
|
|
DTGA1
|
[NCBI]
|
8.07309e-05
|
|
|
microduplication 22q11.2
|
[NCBI]
|
8.07309e-05
|
|
|
LALL
|
[NCBI]
|
8.07309e-05
|
|
|
TBG
|
[NCBI]
|
7.98094e-05
|
|
|
FACL4
|
[NCBI]
|
7.95936e-05
|
|
|
WAS
|
[NCBI]
|
7.94888e-05
|
|
|
TCRD
|
[NCBI]
|
7.94221e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
7.81721e-05
|
|
|
PAX3
|
[NCBI]
|
7.79369e-05
|
|
|
ZNF141
|
[NCBI]
|
7.72341e-05
|
|
|
PRPS1L1
|
[NCBI]
|
7.72341e-05
|
|
|
ovarian cancer-associated gene 2
|
[NCBI]
|
7.72341e-05
|
|
|
SLC7A4
|
[NCBI]
|
7.72341e-05
|
|
|
LUZP2
|
[NCBI]
|
7.72341e-05
|
|
|
C9ORF103
|
[NCBI]
|
7.72341e-05
|
|
|
RASEF
|
[NCBI]
|
7.72341e-05
|
|
|
C2ORF34
|
[NCBI]
|
7.72341e-05
|
|
|
autonomously replicating sequence 1
|
[NCBI]
|
7.72341e-05
|
|
|
HECA
|
[NCBI]
|
7.72341e-05
|
|
|
ZNF74
|
[NCBI]
|
7.72341e-05
|
|
|
TSPAN33
|
[NCBI]
|
7.72341e-05
|
|
|
C9ORF64
|
[NCBI]
|
7.72341e-05
|
|
|
f-box only protein 47
|
[NCBI]
|
7.72341e-05
|
|
|
PLCL1
|
[NCBI]
|
7.72341e-05
|
|
|
IGKDEL
|
[NCBI]
|
7.72341e-05
|
|
|
methylation modifier for class i hla
|
[NCBI]
|
7.72341e-05
|
|
|
ST2
|
[NCBI]
|
7.72341e-05
|
|
|
leucine zipper transcription factor-like 1
|
[NCBI]
|
7.72341e-05
|
|
|
COL4A5
|
[NCBI]
|
7.72177e-05
|
|
|
SEMA3B
|
[NCBI]
|
7.70164e-05
|
|
|
melanoma, uveal
|
[NCBI]
|
7.64329e-05
|
|
|
HPRT1
|
[NCBI]
|
7.57417e-05
|
|
|
pierre robin syndrome
|
[NCBI]
|
7.54624e-05
|
|
|
HPA1
|
[NCBI]
|
7.42901e-05
|
|
|
RASSF1
|
[NCBI]
|
7.39869e-05
|
|
|
XG
|
[NCBI]
|
7.39869e-05
|
|
|
NEFH
|
[NCBI]
|
7.3137e-05
|
|
|
GDXY
|
[NCBI]
|
7.29653e-05
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
7.21587e-05
|
|
|
VDR
|
[NCBI]
|
7.17698e-05
|
|
|
NQO1
|
[NCBI]
|
7.17279e-05
|
|
|
coats disease
|
[NCBI]
|
7.16063e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
7.12672e-05
|
|
|
weaver syndrome
|
[NCBI]
|
7.12344e-05
|
|
|
PAX1
|
[NCBI]
|
7.0924e-05
|
|
|
ABCA1
|
[NCBI]
|
7.07769e-05
|
|
|
CREBBP
|
[NCBI]
|
7.07769e-05
|
|
|
CHAT
|
[NCBI]
|
7.05222e-05
|
|
|
CBL
|
[NCBI]
|
7.02766e-05
|
|
|
PRPH2
|
[NCBI]
|
7.01487e-05
|
|
|
OA1
|
[NCBI]
|
6.91631e-05
|
|
|
HPE5
|
[NCBI]
|
6.90216e-05
|
|
|
trigonocephaly, nonsyndromic
|
[NCBI]
|
6.90216e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
6.90216e-05
|
|
|
choroideremia with deafness and obesity
|
[NCBI]
|
6.90216e-05
|
|
|
ependymoma, familial
|
[NCBI]
|
6.90216e-05
|
|
|
CSB
|
[NCBI]
|
6.90216e-05
|
|
|
cervical cancer
|
[NCBI]
|
6.90216e-05
|
|
|
SPG7
|
[NCBI]
|
6.90216e-05
|
|
|
GKAP1
|
[NCBI]
|
6.90199e-05
|
|
|
NME5
|
[NCBI]
|
6.90199e-05
|
|
|
SACM1L
|
[NCBI]
|
6.90199e-05
|
|
|
ZIC4
|
[NCBI]
|
6.90199e-05
|
|
|
TTTY17
|
[NCBI]
|
6.90199e-05
|
|
|
TTTY4
|
[NCBI]
|
6.90199e-05
|
|
|
MLL3
|
[NCBI]
|
6.90199e-05
|
|
|
CSPG4LY
|
[NCBI]
|
6.90199e-05
|
|
|
REEP2
|
[NCBI]
|
6.90199e-05
|
|
|
IL1RAPL2
|
[NCBI]
|
6.90199e-05
|
|
|
WBSCR1
|
[NCBI]
|
6.90199e-05
|
|
|
GOLGA2LY
|
[NCBI]
|
6.90199e-05
|
|
|
APPL2
|
[NCBI]
|
6.90199e-05
|
|
|
FBXL13
|
[NCBI]
|
6.90199e-05
|
|
|
TTTY3
|
[NCBI]
|
6.90199e-05
|
|
|
PLCB4
|
[NCBI]
|
6.90199e-05
|
|
|
RARS1
|
[NCBI]
|
6.90199e-05
|
|
|
TTTY5
|
[NCBI]
|
6.90199e-05
|
|
|
TTTY6
|
[NCBI]
|
6.90199e-05
|
|
|
CDKL3
|
[NCBI]
|
6.90199e-05
|
|
|
COPS3
|
[NCBI]
|
6.90199e-05
|
|
|
MNGIE
|
[NCBI]
|
6.82883e-05
|
|
|
RAF1
|
[NCBI]
|
6.80176e-05
|
|
|
VHL
|
[NCBI]
|
6.77362e-05
|
|
|
JPS
|
[NCBI]
|
6.73386e-05
|
|
|
SMARCB1
|
[NCBI]
|
6.70621e-05
|
|
|
SRY
|
[NCBI]
|
6.65565e-05
|
|
|
keutel syndrome
|
[NCBI]
|
6.61075e-05
|
|
|
RAC3
|
[NCBI]
|
6.59404e-05
|
|
|
ARHGAP20
|
[NCBI]
|
6.59404e-05
|
|
|
MTIF2
|
[NCBI]
|
6.59404e-05
|
|
|
PCDH21
|
[NCBI]
|
6.59404e-05
|
|
|
THRAP2
|
[NCBI]
|
6.59404e-05
|
|
|
PCDHA8
|
[NCBI]
|
6.59404e-05
|
|
|
GMFG
|
[NCBI]
|
6.59404e-05
|
|
|
STK25
|
[NCBI]
|
6.59404e-05
|
|
|
ILF1
|
[NCBI]
|
6.59404e-05
|
|
|
PCDHA10
|
[NCBI]
|
6.59404e-05
|
|
|
GMDS
|
[NCBI]
|
6.59404e-05
|
|
|
ATG12
|
[NCBI]
|
6.59404e-05
|
|
|
LARS
|
[NCBI]
|
6.59404e-05
|
|
|
TP53
|
[NCBI]
|
6.5409e-05
|
|
|
AFP
|
[NCBI]
|
6.534358e-05
|
|
|
larynx, congenital partial atresia of
|
[NCBI]
|
6.51655e-05
|
|
|
myelocerebellar disorder
|
[NCBI]
|
6.51655e-05
|
|
|
IL3
|
[NCBI]
|
6.45816e-05
|
|
|
CGD
|
[NCBI]
|
6.44353e-05
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
6.43264e-05
|
|
|
IFNB1
|
[NCBI]
|
6.42395e-05
|
|
|
COL2A1
|
[NCBI]
|
6.41208e-05
|
|
|
tracheoesophageal fistula with or without esophageal atresia
|
[NCBI]
|
6.40236e-05
|
|
|
KCNC1
|
[NCBI]
|
6.39523e-05
|
|
|
HARS
|
[NCBI]
|
6.39523e-05
|
|
|
RFC2
|
[NCBI]
|
6.39523e-05
|
|
|
CALB2
|
[NCBI]
|
6.39523e-05
|
|
|
OCM
|
[NCBI]
|
6.39523e-05
|
|
|
CTNND2
|
[NCBI]
|
6.39523e-05
|
|
|
SFRS7
|
[NCBI]
|
6.39523e-05
|
|
|
FBXO4
|
[NCBI]
|
6.39523e-05
|
|
|
ZNF35
|
[NCBI]
|
6.39523e-05
|
|
|
ING3
|
[NCBI]
|
6.39523e-05
|
|
|
UTY
|
[NCBI]
|
6.39523e-05
|
|
|
FBXW2
|
[NCBI]
|
6.39523e-05
|
|
|
TLE4
|
[NCBI]
|
6.39523e-05
|
|
|
GRID1
|
[NCBI]
|
6.39523e-05
|
|
|
CTDSPL
|
[NCBI]
|
6.39523e-05
|
|
|
sotos syndrome
|
[NCBI]
|
6.39022e-05
|
|
|
CUTL1
|
[NCBI]
|
6.3824e-05
|
|
|
YWHAG
|
[NCBI]
|
6.24826e-05
|
|
|
ARHGAP26
|
[NCBI]
|
6.24826e-05
|
|
|
PCDHA9
|
[NCBI]
|
6.24826e-05
|
|
|
LAP3
|
[NCBI]
|
6.24826e-05
|
|
|
AK3L1
|
[NCBI]
|
6.24826e-05
|
|
|
MAFD6
|
[NCBI]
|
6.17498e-05
|
|
|
IGHD
|
[NCBI]
|
6.13182e-05
|
|
|
FBXO5
|
[NCBI]
|
6.13182e-05
|
|
|
ENO2
|
[NCBI]
|
6.13182e-05
|
|
|
FBXL3
|
[NCBI]
|
6.13182e-05
|
|
|
LDHA
|
[NCBI]
|
6.09769e-05
|
|
|
CRS2
|
[NCBI]
|
6.06594e-05
|
|
|
RP7
|
[NCBI]
|
6.04703e-05
|
|
|
hunter-mcalpine craniosynostosis syndrome
|
[NCBI]
|
6.04703e-05
|
|
|
POF2A
|
[NCBI]
|
6.04703e-05
|
|
|
AVSD2
|
[NCBI]
|
6.04703e-05
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
6.04703e-05
|
|
|
TXNRD2
|
[NCBI]
|
6.03555e-05
|
|
|
MEOX1
|
[NCBI]
|
6.03555e-05
|
|
|
PRB2
|
[NCBI]
|
6.03555e-05
|
|
|
CSF1
|
[NCBI]
|
5.98721e-05
|
|
|
DBT
|
[NCBI]
|
5.98721e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
5.98034e-05
|
|
|
marshall-smith syndrome
|
[NCBI]
|
5.96667e-05
|
|
|
ruvalcaba syndrome
|
[NCBI]
|
5.96667e-05
|
|
|
LRPAP1
|
[NCBI]
|
5.95362e-05
|
|
|
SOX2
|
[NCBI]
|
5.90448e-05
|
|
|
CD28
|
[NCBI]
|
5.81951e-05
|
|
|
ACP1
|
[NCBI]
|
5.80668e-05
|
|
|
RP2
|
[NCBI]
|
5.77968e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
5.7446e-05
|
|
|
EXT2
|
[NCBI]
|
5.72062e-05
|
|
|
COL3A1
|
[NCBI]
|
5.70513e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
5.68033e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
5.67277e-05
|
|
|
IDH1
|
[NCBI]
|
5.66618e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
5.58233e-05
|
|
|
PGM1
|
[NCBI]
|
5.56027e-05
|
|
|
PCCB
|
[NCBI]
|
5.54826e-05
|
|
|
GUSB
|
[NCBI]
|
5.53703e-05
|
|
|
NF2
|
[NCBI]
|
5.53343e-05
|
|
|
downregulated in renal cell carcinoma 1
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF154
|
[NCBI]
|
5.53328e-05
|
|
|
MLL5
|
[NCBI]
|
5.53328e-05
|
|
|
C17ORF41
|
[NCBI]
|
5.53328e-05
|
|
|
C5ORF5
|
[NCBI]
|
5.53328e-05
|
|
|
BPY2
|
[NCBI]
|
5.53328e-05
|
|
|
PDGFRL
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF138
|
[NCBI]
|
5.53328e-05
|
|
|
CHD5
|
[NCBI]
|
5.53328e-05
|
|
|
LHFP
|
[NCBI]
|
5.53328e-05
|
|
|
myeloid leukemia-related gene
|
[NCBI]
|
5.53328e-05
|
|
|
TUSC2
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF134
|
[NCBI]
|
5.53328e-05
|
|
|
MRX49
|
[NCBI]
|
5.53328e-05
|
|
|
e2f-associated phosphoprotein
|
[NCBI]
|
5.53328e-05
|
|
|
TWISTNB
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF131
|
[NCBI]
|
5.53328e-05
|
|
|
DEC1
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF155
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF135
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF132
|
[NCBI]
|
5.53328e-05
|
|
|
DLEU1
|
[NCBI]
|
5.53328e-05
|
|
|
ZNF137
|
[NCBI]
|
5.53328e-05
|
|
|
WS1
|
[NCBI]
|
5.52618e-05
|
|
|
TCRG
|
[NCBI]
|
5.46721e-05
|
|
|
NPS
|
[NCBI]
|
5.46422e-05
|
|
|
CDH1
|
[NCBI]
|
5.43649e-05
|
|
|
CES
|
[NCBI]
|
5.434e-05
|
|
|
ABO
|
[NCBI]
|
5.40595e-05
|
|
|
HPE4
|
[NCBI]
|
5.3779e-05
|
|
|
tibial hemimelia
|
[NCBI]
|
5.3779e-05
|
|
|
clark-baraitser syndrome
|
[NCBI]
|
5.3779e-05
|
|
|
neural tube defects
|
[NCBI]
|
5.30935e-05
|
|
|
eunuchoidism, familial hypogonadotropic
|
[NCBI]
|
5.28876e-05
|
|
|
ZNF136
|
[NCBI]
|
5.22533e-05
|
|
|
DPH1
|
[NCBI]
|
5.22533e-05
|
|
|
NHP2L1
|
[NCBI]
|
5.22533e-05
|
|
|
TCF9
|
[NCBI]
|
5.22533e-05
|
|
|
SHROOM2
|
[NCBI]
|
5.22533e-05
|
|
|
ORC5L
|
[NCBI]
|
5.22533e-05
|
|
|
HNRPA0
|
[NCBI]
|
5.22533e-05
|
|
|
ZKSCAN1
|
[NCBI]
|
5.22533e-05
|
|
|
ZNF142
|
[NCBI]
|
5.22533e-05
|
|
|
FOXL1
|
[NCBI]
|
5.22533e-05
|
|
|
SEZ6L
|
[NCBI]
|
5.22533e-05
|
|
|
PRY2
|
[NCBI]
|
5.22533e-05
|
|
|
ATP6V0E1
|
[NCBI]
|
5.22533e-05
|
|
|
BRWD3
|
[NCBI]
|
5.22533e-05
|
|
|
APPL1
|
[NCBI]
|
5.22533e-05
|
|
|
PFDN4
|
[NCBI]
|
5.22533e-05
|
|
|
DRG2
|
[NCBI]
|
5.22533e-05
|
|
|
VWS
|
[NCBI]
|
5.22532e-05
|
|
|
APOC2
|
[NCBI]
|
5.14517e-05
|
|
|
ITGA2B
|
[NCBI]
|
5.11671e-05
|
|
|
CLN3
|
[NCBI]
|
5.05273e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
5.03537e-05
|
|
|
FAM123B
|
[NCBI]
|
5.02652e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
5.02652e-05
|
|
|
ZNF133
|
[NCBI]
|
5.02652e-05
|
|
|
ZNF140
|
[NCBI]
|
5.02652e-05
|
|
|
ZIC1
|
[NCBI]
|
5.02652e-05
|
|
|
SLC28A3
|
[NCBI]
|
5.02652e-05
|
|
|
GPC1
|
[NCBI]
|
5.02652e-05
|
|
|
GK
|
[NCBI]
|
5.01715e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
4.95307e-05
|
|
|
FXYD2
|
[NCBI]
|
4.87955e-05
|
|
|
PDHB
|
[NCBI]
|
4.87955e-05
|
|
|
CRK
|
[NCBI]
|
4.87955e-05
|
|
|
ZNF151
|
[NCBI]
|
4.87955e-05
|
|
|
AKT3
|
[NCBI]
|
4.87955e-05
|
|
|
CCM3
|
[NCBI]
|
4.83167e-05
|
|
|
amme complex
|
[NCBI]
|
4.83167e-05
|
|
|
chromosome 16p13.3 deletion syndrome
|
[NCBI]
|
4.83167e-05
|
|
|
SDHD
|
[NCBI]
|
4.78885e-05
|
|
|
FN1
|
[NCBI]
|
4.78672e-05
|
|
|
RHO
|
[NCBI]
|
4.77455e-05
|
|
|
FOXF2
|
[NCBI]
|
4.76311e-05
|
|
|
DCP2
|
[NCBI]
|
4.76311e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
4.71973e-05
|
|
|
kinesin family member 27, kif27
|
[NCBI]
|
4.71456e-05
|
|
|
ARL11
|
[NCBI]
|
4.71456e-05
|
|
|
CYLN2
|
[NCBI]
|
4.71456e-05
|
|
|
IPW
|
[NCBI]
|
4.71456e-05
|
|
|
UFD1L
|
[NCBI]
|
4.71456e-05
|
|
|
PDCD10
|
[NCBI]
|
4.71456e-05
|
|
|
CHL1
|
[NCBI]
|
4.71456e-05
|
|
|
MUC1
|
[NCBI]
|
4.711015e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.69627e-05
|
|
|
NR2E1
|
[NCBI]
|
4.66684e-05
|
|
|
ZNF143
|
[NCBI]
|
4.66684e-05
|
|
|
CYP2B6
|
[NCBI]
|
4.66684e-05
|
|
|
TPI1
|
[NCBI]
|
4.65475e-05
|
|
|
RP
|
[NCBI]
|
4.64333e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
4.61425e-05
|
|
|
PAFAH1B1
|
[NCBI]
|
4.61037e-05
|
|
|
INSR
|
[NCBI]
|
4.6003e-05
|
|
|
C4A
|
[NCBI]
|
4.58613e-05
|
|
|
TNNC1
|
[NCBI]
|
4.58491e-05
|
|
|
GOPC
|
[NCBI]
|
4.58491e-05
|
|
|
HYR
|
[NCBI]
|
4.58118e-05
|
|
|
PEPD
|
[NCBI]
|
4.57922e-05
|
|
|
RMI1
|
[NCBI]
|
4.51575e-05
|
|
|
NKX3A
|
[NCBI]
|
4.51575e-05
|
|
|
RNF6
|
[NCBI]
|
4.51575e-05
|
|
|
GART
|
[NCBI]
|
4.51369e-05
|
|
|
MAOA
|
[NCBI]
|
4.49082e-05
|
|
|
GAS1
|
[NCBI]
|
4.4508e-05
|
|
|
IGHE
|
[NCBI]
|
4.4508e-05
|
|
|
GLI3
|
[NCBI]
|
4.42586e-05
|
|
|
BL
|
[NCBI]
|
4.42089e-05
|
|
|
HBG2
|
[NCBI]
|
4.41659e-05
|
|
|
FOXF1
|
[NCBI]
|
4.39456e-05
|
|
|
MDH1
|
[NCBI]
|
4.39456e-05
|
|
|
SMPD1
|
[NCBI]
|
4.38586e-05
|
|
|
testicular tumors
|
[NCBI]
|
4.38454e-05
|
|
|
MRX9
|
[NCBI]
|
4.37279e-05
|
|
|
CORT
|
[NCBI]
|
4.36878e-05
|
|
|
NR2C2
|
[NCBI]
|
4.36878e-05
|
|
|
LGALS2
|
[NCBI]
|
4.36878e-05
|
|
|
SMAD4
|
[NCBI]
|
4.35057e-05
|
|
|
ARSA
|
[NCBI]
|
4.30137e-05
|
|
|
NLGN4
|
[NCBI]
|
4.25234e-05
|
|
|
TLE1
|
[NCBI]
|
4.25234e-05
|
|
|
FER
|
[NCBI]
|
4.25234e-05
|
|
|
IGHA2
|
[NCBI]
|
4.25234e-05
|
|
|
IFI6
|
[NCBI]
|
4.25234e-05
|
|
|
von willebrand disease
|
[NCBI]
|
4.2515e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
4.19361e-05
|
|
|
FKBP6
|
[NCBI]
|
4.18734e-05
|
|
|
BCNS
|
[NCBI]
|
4.17628e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
4.15841e-05
|
|
|
DBY
|
[NCBI]
|
4.15607e-05
|
|
|
RBMY1A1
|
[NCBI]
|
4.15607e-05
|
|
|
locus control region, beta
|
[NCBI]
|
4.15607e-05
|
|
|
HLA-F
|
[NCBI]
|
4.15607e-05
|
|
|
complement component 5 deficiency
|
[NCBI]
|
4.1492e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
4.145631e-05
|
|
|
CMPK1
|
[NCBI]
|
4.113966e-05
|
|
|
CLDN4
|
[NCBI]
|
4.07414e-05
|
|
|
BMP5
|
[NCBI]
|
4.07414e-05
|
|
|
PLCG1
|
[NCBI]
|
4.07414e-05
|
|
|
ROBO1
|
[NCBI]
|
4.07414e-05
|
|
|
AP1B1
|
[NCBI]
|
4.04037e-05
|
|
|
CRKL
|
[NCBI]
|
4.04037e-05
|
|
|
CCKBR
|
[NCBI]
|
4.00292e-05
|
|
|
IGFBP2
|
[NCBI]
|
4.00292e-05
|
|
|
HDAC9
|
[NCBI]
|
4.00292e-05
|
|
|
heat-shock protein, 75-kd
|
[NCBI]
|
4.00292e-05
|
|
|
OCA3
|
[NCBI]
|
3.97923e-05
|
|
|
MODY2
|
[NCBI]
|
3.97923e-05
|
|
|
OXTR
|
[NCBI]
|
3.94003e-05
|
|
|
TSPY
|
[NCBI]
|
3.94003e-05
|
|
|
LMO1
|
[NCBI]
|
3.92393e-05
|
|
|
NHEJ1
|
[NCBI]
|
3.92393e-05
|
|
|
ASPH
|
[NCBI]
|
3.92393e-05
|
|
|
ATOX1
|
[NCBI]
|
3.92393e-05
|
|
|
MGP
|
[NCBI]
|
3.92393e-05
|
|
|
WBSCR14
|
[NCBI]
|
3.92393e-05
|
|
|
HNRNPK
|
[NCBI]
|
3.92393e-05
|
|
|
KCS
|
[NCBI]
|
3.89871e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
3.89871e-05
|
|
|
APH
|
[NCBI]
|
3.88379e-05
|
|
|
G6PD
|
[NCBI]
|
3.875524e-05
|
|
|
TTR
|
[NCBI]
|
3.85698e-05
|
|
|
ABCC8
|
[NCBI]
|
3.84248e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
3.83613e-05
|
|
|
TG
|
[NCBI]
|
3.833109e-05
|
|
|
ZNF148
|
[NCBI]
|
3.83298e-05
|
|
|
PCK1
|
[NCBI]
|
3.82766e-05
|
|
|
CKB
|
[NCBI]
|
3.82766e-05
|
|
|
HES
|
[NCBI]
|
3.82272e-05
|
|
|
NBL1
|
[NCBI]
|
3.79857e-05
|
|
|
CCT
|
[NCBI]
|
3.79857e-05
|
|
|
DBC1
|
[NCBI]
|
3.79857e-05
|
|
|
CSMD1
|
[NCBI]
|
3.79857e-05
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
3.79286e-05
|
|
|
lipomatosis, familial benign cervical
|
[NCBI]
|
3.77513e-05
|
|
|
XLP1
|
[NCBI]
|
3.76152e-05
|
|
|
FIH
|
[NCBI]
|
3.74691e-05
|
|
|
PTPRG
|
[NCBI]
|
3.74573e-05
|
|
|
NR2F2
|
[NCBI]
|
3.74573e-05
|
|
|
SLC25A1
|
[NCBI]
|
3.705059e-05
|
|
|
DVL1
|
[NCBI]
|
3.705059e-05
|
|
|
OCA2
|
[NCBI]
|
3.69902e-05
|
|
|
GPC5
|
[NCBI]
|
3.68213e-05
|
|
|
PGAM1
|
[NCBI]
|
3.67451e-05
|
|
|
PVALB
|
[NCBI]
|
3.67451e-05
|
|
|
NME2
|
[NCBI]
|
3.67451e-05
|
|
|
CDC2L1
|
[NCBI]
|
3.67451e-05
|
|
|
TNFRSF9
|
[NCBI]
|
3.67451e-05
|
|
|
PTEN
|
[NCBI]
|
3.64599e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
3.63635e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
3.62888e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
3.61142e-05
|
|
|
SATB2
|
[NCBI]
|
3.58586e-05
|
|
|
CLDN3
|
[NCBI]
|
3.55538e-05
|
|
|
SLOS
|
[NCBI]
|
3.5371e-05
|
|
|
IGHV
|
[NCBI]
|
3.519094e-05
|
|
|
LCP1
|
[NCBI]
|
3.519094e-05
|
|
|
PDHA1
|
[NCBI]
|
3.51132e-05
|
|
|
PCBD1
|
[NCBI]
|
3.50393e-05
|
|
|
CRYBB1
|
[NCBI]
|
3.50393e-05
|
|
|
YWHAE
|
[NCBI]
|
3.50393e-05
|
|
|
PSPH
|
[NCBI]
|
3.50393e-05
|
|
|
pseudotrisomy 13 syndrome
|
[NCBI]
|
3.49796e-05
|
|
|
PJS
|
[NCBI]
|
3.49601e-05
|
|
|
ALG6
|
[NCBI]
|
3.49134e-05
|
|
|
LIS1
|
[NCBI]
|
3.4832e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
3.4832e-05
|
|
|
HEXA
|
[NCBI]
|
3.48278e-05
|
|
|
ASMD
|
[NCBI]
|
3.47237e-05
|
|
|
SRC
|
[NCBI]
|
3.45179e-05
|
|
|
IGFBP5
|
[NCBI]
|
3.43271e-05
|
|
|
SEMA5A
|
[NCBI]
|
3.43271e-05
|
|
|
PDGFA
|
[NCBI]
|
3.43271e-05
|
|
|
CHRND
|
[NCBI]
|
3.43271e-05
|
|
|
DNASE1
|
[NCBI]
|
3.43271e-05
|
|
|
GOT1
|
[NCBI]
|
3.41583e-05
|
|
|
IL1RAPL1
|
[NCBI]
|
3.39507e-05
|
|
|
CYP17A1
|
[NCBI]
|
3.38925e-05
|
|
|
aceruloplasminemia
|
[NCBI]
|
3.38697e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
3.38332e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
3.37438e-05
|
|
|
CCNC
|
[NCBI]
|
3.36982e-05
|
|
|
currarino syndrome
|
[NCBI]
|
3.34866e-05
|
|
|
KITLG
|
[NCBI]
|
3.341302e-05
|
|
|
FOXA2
|
[NCBI]
|
3.340308e-05
|
|
|
GNAS
|
[NCBI]
|
3.32999e-05
|
|
|
OCA1A
|
[NCBI]
|
3.31466e-05
|
|
|
ROS1
|
[NCBI]
|
3.31314e-05
|
|
|
BCL3
|
[NCBI]
|
3.31314e-05
|
|
|
aging
|
[NCBI]
|
3.30785e-05
|
|
|
breast cancer
|
[NCBI]
|
3.30734e-05
|
|
|
CD99
|
[NCBI]
|
3.306451e-05
|
|
|
phenylketonuria
|
[NCBI]
|
3.27197e-05
|
|
|
PFN1
|
[NCBI]
|
3.26277e-05
|
|
|
c syndrome
|
[NCBI]
|
3.25675e-05
|
|
|
Ge
|
[NCBI]
|
3.245068e-05
|
|
|
TOP3A
|
[NCBI]
|
3.24192e-05
|
|
|
FIP1L1
|
[NCBI]
|
3.23799e-05
|
|
|
HMI
|
[NCBI]
|
3.23167e-05
|
|
|
MSN
|
[NCBI]
|
3.21649e-05
|
|
|
SPN
|
[NCBI]
|
3.21649e-05
|
|
|
WSS
|
[NCBI]
|
3.2104e-05
|
|
|
HNPCC2
|
[NCBI]
|
3.2104e-05
|
|
|
POLG
|
[NCBI]
|
3.20554e-05
|
|
|
PARP1
|
[NCBI]
|
3.175164e-05
|
|
|
MXI1
|
[NCBI]
|
3.12279e-05
|
|
|
CDL1
|
[NCBI]
|
3.09914e-05
|
|
|
TUBB
|
[NCBI]
|
3.098508e-05
|
|
|
JARID1D
|
[NCBI]
|
3.098508e-05
|
|
|
BCKDHB
|
[NCBI]
|
3.08484e-05
|
|
|
GTF2IRD1
|
[NCBI]
|
3.08484e-05
|
|
|
MSH3
|
[NCBI]
|
3.07198e-05
|
|
|
HHF1
|
[NCBI]
|
3.06844e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
3.06472e-05
|
|
|
PPD2
|
[NCBI]
|
3.06472e-05
|
|
|
ITGB2
|
[NCBI]
|
3.04388e-05
|
|
|
OMP
|
[NCBI]
|
3.041713e-05
|
|
|
EN1
|
[NCBI]
|
3.032986e-05
|
|
|
KIT
|
[NCBI]
|
3.02579e-05
|
|
|
POLR2A
|
[NCBI]
|
3.021445e-05
|
|
|
DLG1
|
[NCBI]
|
3.004278e-05
|
|
|
PIM1
|
[NCBI]
|
2.98324e-05
|
|
|
EN2
|
[NCBI]
|
2.98324e-05
|
|
|
WRN
|
[NCBI]
|
2.96344e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
2.95346e-05
|
|
|
TDG
|
[NCBI]
|
2.923894e-05
|
|
|
RARB
|
[NCBI]
|
2.9149e-05
|
|
|
TAP1
|
[NCBI]
|
2.907718e-05
|
|
|
BDC
|
[NCBI]
|
2.9064e-05
|
|
|
PRKCA
|
[NCBI]
|
2.873861e-05
|
|
|
CTNNA1
|
[NCBI]
|
2.86862e-05
|
|
|
ITGB3
|
[NCBI]
|
2.86542e-05
|
|
|
PAK2
|
[NCBI]
|
2.842196e-05
|
|
|
SIM2
|
[NCBI]
|
2.83651e-05
|
|
|
SCZD4
|
[NCBI]
|
2.83377e-05
|
|
|
INHA
|
[NCBI]
|
2.83259e-05
|
|
|
MCF2
|
[NCBI]
|
2.82616e-05
|
|
|
LDS
|
[NCBI]
|
2.82302e-05
|
|
|
BOS1
|
[NCBI]
|
2.82224e-05
|
|
|
JUP
|
[NCBI]
|
2.786979e-05
|
|
|
PLCB3
|
[NCBI]
|
2.77362e-05
|
|
|
ADA
|
[NCBI]
|
2.7387e-05
|
|
|
FES
|
[NCBI]
|
2.7355e-05
|
|
|
ID3
|
[NCBI]
|
2.7355e-05
|
|
|
NPHP1
|
[NCBI]
|
2.71738e-05
|
|
|
PLAGL1
|
[NCBI]
|
2.71738e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
2.70545e-05
|
|
|
MEN1
|
[NCBI]
|
2.67673e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
2.67656e-05
|
|
|
SNCG
|
[NCBI]
|
2.67231e-05
|
|
|
KRT2A
|
[NCBI]
|
2.67231e-05
|
|
|
TBX3
|
[NCBI]
|
2.66657e-05
|
|
|
DGUOK
|
[NCBI]
|
2.66657e-05
|
|
|
DAPK1
|
[NCBI]
|
2.66657e-05
|
|
|
UBQLN1
|
[NCBI]
|
2.66657e-05
|
|
|
TAL1
|
[NCBI]
|
2.655398e-05
|
|
|
ACY1
|
[NCBI]
|
2.655398e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
2.63028e-05
|
|
|
SEPT9
|
[NCBI]
|
2.62029e-05
|
|
|
DRD5
|
[NCBI]
|
2.617518e-05
|
|
|
PIK3R1
|
[NCBI]
|
2.617518e-05
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
2.60462e-05
|
|
|
CALCR
|
[NCBI]
|
2.57783e-05
|
|
|
C10ORF2
|
[NCBI]
|
2.56526e-05
|
|
|
ACADM
|
[NCBI]
|
2.551522e-05
|
|
|
LWD
|
[NCBI]
|
2.55149e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
2.54612e-05
|
|
|
AIS
|
[NCBI]
|
2.54407e-05
|
|
|
FSHB
|
[NCBI]
|
2.538649e-05
|
|
|
GALR1
|
[NCBI]
|
2.538649e-05
|
|
|
ETS2
|
[NCBI]
|
2.538649e-05
|
|
|
DDC
|
[NCBI]
|
2.522933e-05
|
|
|
SLC1A3
|
[NCBI]
|
2.502308e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.468451e-05
|
|
|
FTH1
|
[NCBI]
|
2.467894e-05
|
|
|
CTCF
|
[NCBI]
|
2.455732e-05
|
|
|
DNAH11
|
[NCBI]
|
2.437339e-05
|
|
|
MT1A
|
[NCBI]
|
2.437339e-05
|
|
|
RTT
|
[NCBI]
|
2.437188e-05
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
2.42878e-05
|
|
|
WWOX
|
[NCBI]
|
2.42878e-05
|
|
|
ACHM2
|
[NCBI]
|
2.42855e-05
|
|
|
TMAU
|
[NCBI]
|
2.413383e-05
|
|
|
CD40
|
[NCBI]
|
2.407068e-05
|
|
|
SLSN1
|
[NCBI]
|
2.385883e-05
|
|
|
EP300
|
[NCBI]
|
2.379092e-05
|
|
|
TYMS
|
[NCBI]
|
2.367046e-05
|
|
|
OCRL
|
[NCBI]
|
2.34766e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
2.347335e-05
|
|
|
CD14
|
[NCBI]
|
2.347139e-05
|
|
|
HIC1
|
[NCBI]
|
2.347139e-05
|
|
|
GNRH1
|
[NCBI]
|
2.34143e-05
|
|
|
LDHB
|
[NCBI]
|
2.335245e-05
|
|
|
SLC7A9
|
[NCBI]
|
2.32038e-05
|
|
|
LIG4
|
[NCBI]
|
2.310798e-05
|
|
|
IGF2R
|
[NCBI]
|
2.281488e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
2.269815e-05
|
|
|
PCCA
|
[NCBI]
|
2.266019e-05
|
|
|
SLC45A2
|
[NCBI]
|
2.245276e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
2.24464e-05
|
|
|
HEPH
|
[NCBI]
|
2.229678e-05
|
|
|
GAPDH
|
[NCBI]
|
2.228429e-05
|
|
|
IKZF1
|
[NCBI]
|
2.195821e-05
|
|
|
GABRB3
|
[NCBI]
|
2.195821e-05
|
|
|
DSG2
|
[NCBI]
|
2.192459e-05
|
|
|
TECTA
|
[NCBI]
|
2.192459e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
2.173212e-05
|
|
|
FANCD2
|
[NCBI]
|
2.16447e-05
|
|
|
MYO5A
|
[NCBI]
|
2.138262e-05
|
|
|
PFKM
|
[NCBI]
|
2.134438e-05
|
|
|
AR
|
[NCBI]
|
2.132366e-05
|
|
|
RPS6
|
[NCBI]
|
2.100036e-05
|
|
|
MFS
|
[NCBI]
|
2.078329e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
2.076262e-05
|
|
|
TNXB
|
[NCBI]
|
2.055064e-05
|
|
|
DCX
|
[NCBI]
|
2.055064e-05
|
|
|
UMS
|
[NCBI]
|
2.045725e-05
|
|
|
SOST
|
[NCBI]
|
2.045725e-05
|
|
|
IL9
|
[NCBI]
|
2.032902e-05
|
|
|
KCNQ2
|
[NCBI]
|
2.027258e-05
|
|
|
GATA3
|
[NCBI]
|
2.008839e-05
|
|
|
PGR
|
[NCBI]
|
2.008667e-05
|
|
|
CHRNA4
|
[NCBI]
|
2.006494e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
2.004775e-05
|
|
|
C5
|
[NCBI]
|
1.993708e-05
|
|
|
GLUD1
|
[NCBI]
|
1.993708e-05
|
|
|
CORD2
|
[NCBI]
|
1.987665e-05
|
|
|
AHDS
|
[NCBI]
|
1.987665e-05
|
|
|
CPT2
|
[NCBI]
|
1.981504e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
1.977881e-05
|
|
|
ERCC1
|
[NCBI]
|
1.957803e-05
|
|
|
DLK1
|
[NCBI]
|
1.957803e-05
|
|
|
BRRS
|
[NCBI]
|
1.955275e-05
|
|
|
GDNF
|
[NCBI]
|
1.946459e-05
|
|
|
AMELX
|
[NCBI]
|
1.939324e-05
|
|
|
IVD
|
[NCBI]
|
1.910815e-05
|
|
|
CDK4
|
[NCBI]
|
1.909279e-05
|
|
|
GATA4
|
[NCBI]
|
1.890633e-05
|
|
|
NCF1
|
[NCBI]
|
1.883661e-05
|
|
|
CACNA1S
|
[NCBI]
|
1.877634e-05
|
|
|
HPX
|
[NCBI]
|
1.873845e-05
|
|
|
PLAT
|
[NCBI]
|
1.868109e-05
|
|
|
ANXA5
|
[NCBI]
|
1.868109e-05
|
|
|
HHF2
|
[NCBI]
|
1.861665e-05
|
|
|
MYC
|
[NCBI]
|
1.857085e-05
|
|
|
NME1
|
[NCBI]
|
1.852644e-05
|
|
|
PARK2
|
[NCBI]
|
1.838123e-05
|
|
|
TSC2
|
[NCBI]
|
1.827933e-05
|
|
|
ALB
|
[NCBI]
|
1.824254e-05
|
|
|
TCRB
|
[NCBI]
|
1.820088e-05
|
|
|
HNF1A
|
[NCBI]
|
1.815024e-05
|
|
|
PCD
|
[NCBI]
|
1.812584e-05
|
|
|
ETS1
|
[NCBI]
|
1.806675e-05
|
|
|
AFD1
|
[NCBI]
|
1.788723e-05
|
|
|
IRF1
|
[NCBI]
|
1.784974e-05
|
|
|
FOXC1
|
[NCBI]
|
1.773141e-05
|
|
|
SPG7
|
[NCBI]
|
1.773141e-05
|
|
|
USH1C
|
[NCBI]
|
1.773141e-05
|
|
|
IL4
|
[NCBI]
|
1.769253e-05
|
|
|
CALCA
|
[NCBI]
|
1.752918e-05
|
|
|
SPCH1
|
[NCBI]
|
1.749847e-05
|
|
|
G6PT1
|
[NCBI]
|
1.745165e-05
|
|
|
bladder cancer
|
[NCBI]
|
1.721868e-05
|
|
|
NR4A3
|
[NCBI]
|
1.718757e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
1.704312e-05
|
|
|
UNG
|
[NCBI]
|
1.693356e-05
|
|
|
TIMP1
|
[NCBI]
|
1.691228e-05
|
|
|
NUP98
|
[NCBI]
|
1.675234e-05
|
|
|
DMBT1
|
[NCBI]
|
1.672877e-05
|
|
|
GSTM1
|
[NCBI]
|
1.669346e-05
|
|
|
MBP
|
[NCBI]
|
1.66687e-05
|
|
|
PRODH
|
[NCBI]
|
1.6589e-05
|
|
|
acromegaly
|
[NCBI]
|
1.653613e-05
|
|
|
EBN1
|
[NCBI]
|
1.647214e-05
|
|
|
RAG1
|
[NCBI]
|
1.624655e-05
|
|
|
FOXC2
|
[NCBI]
|
1.624186e-05
|
|
|
IVA
|
[NCBI]
|
1.619393e-05
|
|
|
UROS
|
[NCBI]
|
1.580217e-05
|
|
|
H6PD
|
[NCBI]
|
1.5791e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.568766e-05
|
|
|
TYR
|
[NCBI]
|
1.550362e-05
|
|
|
fabry disease
|
[NCBI]
|
1.544435e-05
|
|
|
IGF1R
|
[NCBI]
|
1.533917e-05
|
|
|
ALD
|
[NCBI]
|
1.52982e-05
|
|
|
HOS
|
[NCBI]
|
1.51868e-05
|
|
|
NKX2E
|
[NCBI]
|
1.516796e-05
|
|
|
PF4
|
[NCBI]
|
1.514192e-05
|
|
|
HNA
|
[NCBI]
|
1.497747e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
1.495358e-05
|
|
|
CD
|
[NCBI]
|
1.489653e-05
|
|
|
TCOF1
|
[NCBI]
|
1.480363e-05
|
|
|
ATR
|
[NCBI]
|
1.480363e-05
|
|
|
IGKC
|
[NCBI]
|
1.478262e-05
|
|
|
PRKAR1A
|
[NCBI]
|
1.460669e-05
|
|
|
IL5
|
[NCBI]
|
1.455951e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
1.449835e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
1.449584e-05
|
|
|
CRYAB
|
[NCBI]
|
1.43822e-05
|
|
|
EYA1
|
[NCBI]
|
1.43822e-05
|
|
|
HNF1B
|
[NCBI]
|
1.423092e-05
|
|
|
ACLS
|
[NCBI]
|
1.413303e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
1.411966e-05
|
|
|
OPA1
|
[NCBI]
|
1.40024e-05
|
|
|
SFRP1
|
[NCBI]
|
1.40024e-05
|
|
|
MKKS
|
[NCBI]
|
1.398845e-05
|
|
|
PAX2
|
[NCBI]
|
1.383103e-05
|
|
|
KAL2
|
[NCBI]
|
1.37493e-05
|
|
|
EV
|
[NCBI]
|
1.374676e-05
|
|
|
SLC25A4
|
[NCBI]
|
1.365172e-05
|
|
|
UBTF
|
[NCBI]
|
1.362048e-05
|
|
|
CYP2D6
|
[NCBI]
|
1.360532e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
1.353235e-05
|
|
|
TPT1
|
[NCBI]
|
1.34936e-05
|
|
|
TYRP1
|
[NCBI]
|
1.340276e-05
|
|
|
TCOF
|
[NCBI]
|
1.320543e-05
|
|
|
thrombocythemia, essential
|
[NCBI]
|
1.306722e-05
|
|
|
polycythemia vera
|
[NCBI]
|
1.270081e-05
|
|
|
ARSB
|
[NCBI]
|
1.263429e-05
|
|
|
MTM1
|
[NCBI]
|
1.257919e-05
|
|
|
BTK
|
[NCBI]
|
1.233843e-05
|
|
|
PITX2
|
[NCBI]
|
1.23303e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
1.2206e-05
|
|
|
PLG
|
[NCBI]
|
1.210884e-05
|
|
|
FGG
|
[NCBI]
|
1.201083e-05
|
|
|
ETV6
|
[NCBI]
|
1.187678e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
1.166494e-05
|
|
|
BBS
|
[NCBI]
|
1.16556e-05
|
|
|
H19
|
[NCBI]
|
1.155679e-05
|
|
|
CPX
|
[NCBI]
|
1.155116e-05
|
|
|
MSH6
|
[NCBI]
|
1.144383e-05
|
|
|
RECQL3
|
[NCBI]
|
1.141911e-05
|
|
|
EBR1
|
[NCBI]
|
1.140739e-05
|
|
|
PMP22
|
[NCBI]
|
1.140153e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.112573e-05
|
|
|
COL17A1
|
[NCBI]
|
1.101899e-05
|
|
|
GDF5
|
[NCBI]
|
1.100936e-05
|
|
|
DAP
|
[NCBI]
|
1.100936e-05
|
|
|
NGFR
|
[NCBI]
|
1.088902e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.086662e-05
|
|
|
NBS1
|
[NCBI]
|
1.086662e-05
|
|
|
SHH
|
[NCBI]
|
1.083396e-05
|
|
|
CYBB
|
[NCBI]
|
1.074176e-05
|
|
|
CMT1A
|
[NCBI]
|
1.072018e-05
|
|
|
GPC3
|
[NCBI]
|
1.069571e-05
|
|
|
EGR1
|
[NCBI]
|
1.030495e-05
|
|
|
lung cancer
|
[NCBI]
|
1.027223e-05
|
|
|
PDGFB
|
[NCBI]
|
1.00971e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
9.9697e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
9.77194e-06
|
|
|
FHIT
|
[NCBI]
|
9.75976e-06
|
|
|
ACH
|
[NCBI]
|
9.74375e-06
|
|
|
MS
|
[NCBI]
|
9.74375e-06
|
|
|
COL1A1
|
[NCBI]
|
9.70612e-06
|
|
|
EWSR1
|
[NCBI]
|
9.60355e-06
|
|
|
GLB1
|
[NCBI]
|
9.46706e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
9.46247e-06
|
|
|
BCL6
|
[NCBI]
|
9.41552e-06
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
9.18871e-06
|
|
|
MMP3
|
[NCBI]
|
9.17747e-06
|
|
|
XPA
|
[NCBI]
|
9.08492e-06
|
|
|
SPG4
|
[NCBI]
|
8.89568e-06
|
|
|
PSACH
|
[NCBI]
|
8.69397e-06
|
|
|
NR5A1
|
[NCBI]
|
8.57247e-06
|
|
|
ATM
|
[NCBI]
|
8.55705e-06
|
|
|
CNC1
|
[NCBI]
|
8.48697e-06
|
|
|
SCZD
|
[NCBI]
|
8.447007e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
8.37003e-06
|
|
|
SPARC
|
[NCBI]
|
8.17124e-06
|
|
|
PPT1
|
[NCBI]
|
8.10432e-06
|
|
|
STGD1
|
[NCBI]
|
8.06143e-06
|
|
|
alzheimer disease 3
|
[NCBI]
|
8.06143e-06
|
|
|
UMOD
|
[NCBI]
|
7.99271e-06
|
|
|
NAT1
|
[NCBI]
|
7.91756e-06
|
|
|
GNRHR
|
[NCBI]
|
7.69059e-06
|
|
|
REN
|
[NCBI]
|
7.69059e-06
|
|
|
NP
|
[NCBI]
|
7.59108e-06
|
|
|
SEDC
|
[NCBI]
|
7.53162e-06
|
|
|
STK11
|
[NCBI]
|
7.50889e-06
|
|
|
BOR1
|
[NCBI]
|
7.50717e-06
|
|
|
charge syndrome
|
[NCBI]
|
7.33338e-06
|
|
|
AVSD
|
[NCBI]
|
7.22626e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
7.15861e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
7.14667e-06
|
|
|
RP3
|
[NCBI]
|
7.11785e-06
|
|
|
FGF1
|
[NCBI]
|
6.961641e-06
|
|
|
GCCR
|
[NCBI]
|
6.66243e-06
|
|
|
ABL1
|
[NCBI]
|
6.56457e-06
|
|
|
EVC
|
[NCBI]
|
6.30854e-06
|
|
|
CDLS1
|
[NCBI]
|
6.27771e-06
|
|
|
LGMD2C
|
[NCBI]
|
6.2672e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
6.1774e-06
|
|
|
GHRH
|
[NCBI]
|
6.10845e-06
|
|
|
CTNNB1
|
[NCBI]
|
6.03834e-06
|
|
|
ZS
|
[NCBI]
|
6.0019e-06
|
|
|
HMBS
|
[NCBI]
|
5.74421e-06
|
|
|
SGBS1
|
[NCBI]
|
5.73656e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
5.64599e-06
|
|
|
F2R
|
[NCBI]
|
5.49667e-06
|
|
|
glycogen storage disease vii
|
[NCBI]
|
5.47752e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
5.45885e-06
|
|
|
WAS
|
[NCBI]
|
5.38662e-06
|
|
|
HSCR1
|
[NCBI]
|
5.19455e-06
|
|
|
ACE
|
[NCBI]
|
5.0203e-06
|
|
|
CP
|
[NCBI]
|
4.98649e-06
|
|
|
MMP2
|
[NCBI]
|
4.96772e-06
|
|
|
MSH2
|
[NCBI]
|
4.91978e-06
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
4.80517e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
4.79209e-06
|
|
|
UGT1A1
|
[NCBI]
|
4.78735e-06
|
|
|
GC
|
[NCBI]
|
4.7284892e-06
|
|
|
cystinuria
|
[NCBI]
|
4.68097e-06
|
|
|
PLP1
|
[NCBI]
|
4.55654e-06
|
|
|
FOXP3
|
[NCBI]
|
4.49961e-06
|
|
|
MC4R
|
[NCBI]
|
4.49227e-06
|
|
|
HD
|
[NCBI]
|
4.46021e-06
|
|
|
BCL2
|
[NCBI]
|
4.39049e-06
|
|
|
CMTX1
|
[NCBI]
|
4.34972e-06
|
|
|
SMA3
|
[NCBI]
|
4.34972e-06
|
|
|
LAD
|
[NCBI]
|
4.193674e-06
|
|
|
SOD1
|
[NCBI]
|
4.1203e-06
|
|
|
CML
|
[NCBI]
|
4.00612e-06
|
|
|
NS1
|
[NCBI]
|
3.93237e-06
|
|
|
COMT
|
[NCBI]
|
3.854864e-06
|
|
|
PGL1
|
[NCBI]
|
3.6422e-06
|
|
|
GLC1A
|
[NCBI]
|
3.57726e-06
|
|
|
LFS1
|
[NCBI]
|
3.38916e-06
|
|
|
CPI
|
[NCBI]
|
3.31787e-06
|
|
|
SLC4A1
|
[NCBI]
|
3.12021e-06
|
|
|
SRS
|
[NCBI]
|
3.11413e-06
|
|
|
BRCA1
|
[NCBI]
|
2.936409e-06
|
|
|
COH1
|
[NCBI]
|
2.92226e-06
|
|
|
ATS
|
[NCBI]
|
2.92226e-06
|
|
|
TSHR
|
[NCBI]
|
2.9063e-06
|
|
|
ABCD1
|
[NCBI]
|
2.902e-06
|
|
|
SMEI
|
[NCBI]
|
2.742713e-06
|
|
|
PRNP
|
[NCBI]
|
2.689845e-06
|
|
|
GPI
|
[NCBI]
|
2.61422e-06
|
|
|
LS
|
[NCBI]
|
2.398492e-06
|
|
|
NRG1
|
[NCBI]
|
2.33639e-06
|
|
|
CLN3
|
[NCBI]
|
2.157531e-06
|
|
|
COMP
|
[NCBI]
|
2.121309e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.102197e-06
|
|
|
ASS
|
[NCBI]
|
1.998423e-06
|
|
|
FMR1
|
[NCBI]
|
1.981105e-06
|
|
|
neuraminidase deficiency
|
[NCBI]
|
1.896315e-06
|
|
|
VMD
|
[NCBI]
|
1.8105e-06
|
|
|
XPA
|
[NCBI]
|
1.8105e-06
|
|
|
SLC6A4
|
[NCBI]
|
1.704413e-06
|
|
|
VHL
|
[NCBI]
|
1.630716e-06
|
|
|
SCS
|
[NCBI]
|
1.623565e-06
|
|
|
BLM
|
[NCBI]
|
1.609459e-06
|
|
|
PDS
|
[NCBI]
|
1.595811e-06
|
|
|
SMA1
|
[NCBI]
|
1.388424e-06
|
|
|
SPINK1
|
[NCBI]
|
1.139699e-06
|
|
|
EDMD
|
[NCBI]
|
1.023145e-06
|
|
|
MAP2
|
[NCBI]
|
9.71079e-07
|
|
|
lynch syndrome i
|
[NCBI]
|
9.6545e-07
|
|
|
APP
|
[NCBI]
|
9.57804157e-07
|
|
|
MTS
|
[NCBI]
|
9.4307829e-07
|
|
|
down syndrome
|
[NCBI]
|
9.32353e-07
|
|
|
homocystinuria
|
[NCBI]
|
9.1092673e-07
|
|
|
DYT1
|
[NCBI]
|
8.6319e-07
|
|
|
PMD
|
[NCBI]
|
8.5023331e-07
|
|
|
HAE
|
[NCBI]
|
8.1087e-07
|
|
|
IAPP
|
[NCBI]
|
7.71434e-07
|
|
|
GHR
|
[NCBI]
|
7.688966e-07
|
|
|
IHH
|
[NCBI]
|
7.378582e-07
|
|
|
PPARG
|
[NCBI]
|
6.70611e-07
|
|
|
galactosemia
|
[NCBI]
|
6.57709e-07
|
|
|
PG
|
[NCBI]
|
6.567588e-07
|
|
|
MYOC
|
[NCBI]
|
6.459108e-07
|
|
|
GJB1
|
[NCBI]
|
5.84276e-07
|
|
|
TSD
|
[NCBI]
|
5.69335e-07
|
|
|
FBN1
|
[NCBI]
|
4.9857925e-07
|
|
|
CAT
|
[NCBI]
|
4.75149e-07
|
|
|
AT
|
[NCBI]
|
4.27979e-07
|
|
|
FGFR1
|
[NCBI]
|
4.11751e-07
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
4.02165e-07
|
|
|
PKD1
|
[NCBI]
|
3.852717e-07
|
|
|
TERT
|
[NCBI]
|
3.693193e-07
|
|
|
CCND1
|
[NCBI]
|
3.378515e-07
|
|
|
FCMD
|
[NCBI]
|
3.354364e-07
|
|
|
BRCA2
|
[NCBI]
|
3.10427e-07
|
|
|
prostate cancer
|
[NCBI]
|
2.027464e-07
|
|
|
ILK
|
[NCBI]
|
1.8088641e-07
|
|
|
IL6
|
[NCBI]
|
1.688301e-07
|
|
|
HP
|
[NCBI]
|
1.3937756e-07
|
|
|
SST
|
[NCBI]
|
1.173301e-07
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.086903e-07
|
|
|
APOB
|
[NCBI]
|
9.468152e-08
|
|
|
CLS
|
[NCBI]
|
7.52051e-08
|
|
|
INS
|
[NCBI]
|
2.485087e-08
|
|
|
IP
|
[NCBI]
|
1.733635e-08
|
|